Seeing Is Believing
RXDX is currently covered by 11 analysts with an average price target of $2.27. This is a potential upside of $2.27 (0%) from yesterday's end of day stock price of $0.
Prometheus Biosciences's activity chart (see below) currently has 46 price targets and 54 ratings on display. The stock rating distribution of RXDX is 65.22% BUY and 34.78% HOLD.
Analysts average stock forecasts to be materialized ratio is 79.08% with an average time for these price targets to be met of 100.46 days.
Highest price target for RXDX is $194, Lowest price target is $36, average price target is $2.27.
Most recent stock forecast was given by GREGORY RENZA from RBC on 10-May-2023. First documented stock forecast 06-Apr-2021.
Currently out of the existing stock ratings of RXDX, 15 are a BUY (65.22%), 8 are a HOLD (34.78%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$200
$0.08 (0.04%)
$140
1 years 6 months 10 days ago
(10-May-2023)
5/7 (71.43%)
$5.84 (3.01%)
49
Hold
$160
$-39.92 (-19.97%)
$160
1 years 6 months 10 days ago
(10-May-2023)
1/2 (50%)
$-34.16 (-17.59%)
52
Hold
$139
$-60.92 (-30.47%)
$139
1 years 7 months 2 days ago
(18-Apr-2023)
4/5 (80%)
$-54.5 (-28.17%)
138
Hold
$138
$-61.92 (-30.97%)
$67
1 years 7 months 2 days ago
(18-Apr-2023)
2/3 (66.67%)
$-55.5 (-28.68%)
93
Hold
$200
$0.08 (0.04%)
$139
1 years 7 months 2 days ago
(18-Apr-2023)
5/6 (83.33%)
$6.5 (3.36%)
116
What is RXDX (Prometheus Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on RXDX (Prometheus Biosciences) with a proven track record?
Which analyst has the most public recommendations on RXDX (Prometheus Biosciences)?
Which analyst is the currently most bullish on RXDX (Prometheus Biosciences)?
Which analyst is the currently most reserved on RXDX (Prometheus Biosciences)?